Commentary: Challenging the assumptions of body mass index and mortality in use of extracorporeal membrane oxygenation for adult respiratory distress syndrome

The COVID-19 pandemic delivered unprecedented challenges for the extracorporeal membrane oxygenation (ECMO) community. The demand for extracorporeal gas exchange markedly increased to face the surge in life-threatening respiratory failure from adult respiratory distress syndrome (ARDS). Further, the role of ECMO for patients with cardiopulmonary failure due to COVID-19 rapidly evolved during the pandemic.1-3 In this context, identifying prognostic predictors is essential to enable provision of ECMO support to patients who are the most likely to benefit.
Source: The Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Commentary Source Type: research